Researchers at the University of Würzburg in Bavaria, Germany, are focusing their psoriasis research on a cell type that has received little attention in connection with the skin disease: B lymphocytes.
A new study suggests that insurance coverage of biologics for psoriasis is becoming more challenging. The need for prior authorization is increasing, as are the average time from prior authorization submission to coverage decisions and prior authorization denial rates.
This is an interesting and credible study of infants, suggesting there probably is a link, one expert notes. It remains to be seen whether water softeners and chlorine filters should be recommended one day. Read more on the data.